| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $93.8M | +52.6% |
| SG&A Expense | $33.3M | +2.3% |
| Operating Income | -$125.5M | -20.6% |
| Net Income | -$117.7M | -23.0% |
| EPS (Basic) | -$3.09 | -22.1% |
| EPS (Diluted) | -$3.09 | -22.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.6M | -5.6% |
| Short-term Investments | $56.8M | -45.5% |
| Current Assets | $154.7M | -25.4% |
| Total Assets | $160.2M | -37.9% |
| Current Liabilities | $28.8M | +34.6% |
| Total Liabilities | $30.1M | +30.6% |
| Stockholders' Equity | $130.2M | -44.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.8M | -39.0% |
| Capital Expenditures | $304K | -73.4% |
| Investing Cash Flow | $95.1M | +64.9% |
| Financing Cash Flow | $493K | -24.6% |
| Free Cash Flow | -$101.1M | -37.3% |